This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Neuroglee Therapeutics , a startup developing digitaltherapeutics for people with neurodegenerative diseases, has raised a $10 million Series A led by Openspace Ventures and EDBI. million to develop digitaltherapeutics for neurodegenerative diseases. Neuroglee gets $2.3 Venture investing in elder tech.
With clearance by the FDA and reimbursement by Medicare and commercial insurance, JOGO’s funding round enables them to expand the $380B treatment market without drugs or surgery. JOGO is the first-ever digitaltherapeutics product to use the science of EMG biofeedback to treat neuromuscular diseases.
BrainCheck , a Houston- and Austin-based company developing cognitive healthcare software to aid physicians in detecting and managing this type of care, raised $10 million in Series B funding to expand its R&D and go-to-market capabilities as it works on new digitaltherapeutics for Alzheimer’s and related dementias.
Register Biofourmis , a Sigapore-founded digitaltherapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet?
Every patient is provided a cellular enabled scale, an American Heart Association information book, exercise bands, a Bodytrace blood pressure cuff and a Garmin fitness tracker to help monitor and track their progress throughout the course.
AnataMed, East Orange – $350,000 The medical device company is developing a one-of-a-kind durable back brace that also enables rehabilitative movements to innovatively treat patients with core and back pain. The company will focus on building its digital proprietary platform and easy-to-use digital application.
It will also use the proceeds to expand in digitaltherapeutics, insurance, and international markets. About GOQii Founded in 2014 by Abhishek Sharma, Sachin Janghel, Champ Alreja, and Vishal Gondal, GOQii is a smart-tech-enabled healthcare platform that offers wearable fitness bands, diagnostics, and personal coaching.
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digitaltherapeutics company, today announced that it has received a notice of allowance from the U.S. ” Read more here.
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digitaltherapeutics company, today announced that it has received a notice of allowance from the U.S. ” Read more here.
Historically, most companies developing “digital health” products took great pains to steer clear of product functionality that necessitated FDA oversight. In recent years, however, some new classes of products have been a priori FDA regulated, such as digitaltherapeutics (e.g.
We organize all of the trending information in your field so you don't have to. Join 24,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content